Kalpataru Multiplier Ltd.

Our Bank & DP Click for Online Payment MF portfolio login smart way to invest in gold
Sovereign gold bond(SGB) Exchange trades funds(ETF)
CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

Company Profile
more from company profile
HomeMarkets Company Profile Smart Quotes

Smart Quotes

CIPLA LTD.

NSE : CIPLABSE : 500087ISIN CODE : INE059A01026Industry : Pharmaceuticals & DrugsHouse : Cipla
BSE1578.2578.35 (+5.22 %)
PREV CLOSE () 1499.90
OPEN PRICE () 1514.95
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 122838
TODAY'S LOW / HIGH ()1503.00 1599.00
52 WK LOW / HIGH ()1106.4 1599
NSE1575.0074.95 (+5 %)
PREV CLOSE() 1500.05
OPEN PRICE () 1504.75
BID PRICE (QTY) 1575.00 (27117)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 4687416
TODAY'S LOW / HIGH() 1501.00 1600.00
52 WK LOW / HIGH ()1108.55 1600
BSE NSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1935

Management Info :

Y K Hamied - Chairman Umang Vohra - Managing Director

Registered Office :

Address : Cipla House, Peninsula Business Park,Ganpatrao Kadam Marg,Lower Parel,
Mumbai,
Maharashtra-400013

Phone : 022-24826000

Website : www.cipla.com

Registrar's Details : K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, Luxembourg, MCX
NEWS
26Jul Cipla informs about disclosure
Cipla has informed that the exchange has received the disclosure under R..
26Jul Cipla informs about disclosure
Cipla has informed that it enclosed disclosure under Regulation 29(1) of..
25Jun Cipla informs about updates
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosur..
25Jun USFDA classifies Cipla’s Patalganga ma
United States Food and Drug Administration (USFDA) has classified Cipla’..
22Jun USFDA conducts inspection at Cipla’s m
The United States Food and Drug Administration (USFDA) has conducted an..
Financials
in Millions
QTR Jun 24 ANNUAL 24
Net Profit10559.440772.5
Gross Profit 14304.5 49469.7
Operating Profit 15733.855548.1
Net Sales 45010.5165743.4
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Abbott India (BSE)
 28637.90 (2.27%)
M.Cap ( in Cr)
60853.54
Divi's Lab (BSE)
 4792.15 (5.33%)
M.Cap ( in Cr)
127216.53
Astrazeneca Pharma I (BSE)
 7173.30 (3.40%)
M.Cap ( in Cr)
17933.25
Alkem Laboratories (BSE)
 5295.80 (2.26%)
M.Cap ( in Cr)
63319.23
Hester Biosciences (BSE)
 3206.45 (3.67%)
M.Cap ( in Cr)
2727.68
Shareholding Pattern
PROMOTERS 30.91%
MUTUAL FUNDS/UTI 17.62%
NON-INSTITUTION 16.4%
FI/BANKS/INSURANCE 5.28%
GOVERNMENT 0%
FII 0%
Mf Holding
ATTENTION INVESTORS

Kalpataru Multiplier Ltd.

Kalpataru is a wishful Divine Tree and in present context a widely Trusted, Time tested and Transparent Share Broker, Mutual Fund Distributor and D.P. of this region.

Mobile Trading App
Mobile Trading IOS App
Call Us 0755-4350141/142/143, 9425008895
Mutual Funds 0755-4276725, 4276726
Email Uskmlho@kalpatarumulti.com

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.
SENSEX81332.721292.92 (1.62%)
NIFTY24834.85428.75 (1.76%)
Dow Jones 40589.34654.27 (1.64%)
Nasdaq 17357.88176.16 (1.03%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI